Morphosys launches US subsidiary, appoints lead

In this newly created role, Herron will lead the build of MorphoSys’ US subsidiary with a focus on establishing the company’s commercial capabilities in the US. The MorphoSys US Inc. operations will be located in New Jersey.

Herron, who holds a Bachelor of Arts in Biology and Economics from Lehigh University, Pennsylvania, and an MBA from Georgetown University, Washington D.C., has more than 25 years of leadership positions in commercial, marketing and general management in the global pharmaceutical industry. She joins MorphoSys after her previous role as Executive Vice President and Chief Commercial Officer at ARIAD Pharmaceuticals (today: Takeda). Before that, she worked ten years for Bristol-Myers Squibb, where she served in various roles of increasing leadership. Prior to joining BMS, Herron worked in various marketing roles in oncology for Novartis Oncology and SmithKline Beecham Oncology (today: GSK). 

Herron was also appointed as member of the Board of Directors of MorphoSys US Inc.

The MorphoSys corporate headquarters will remain in Planegg near Munich, Germany.